Loading clinical trials...
Loading clinical trials...
This is a 12-month longitudinal intervention study in adults (18-65 years) with moderate-severe IBS (IBS-SSS ≥175) evaluating a personalized, patient-centered multidisciplinary treatment delivered in ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Linkoeping University
Collaborators
NCT07540312 · IBS (Irritable Bowel Syndrome)
NCT06757491 · Repetitive Transcranial Magnetic Stimulation, Chronic Visceral Pain, and more
NCT07224113 · IBD, Crohn Disease (CD), and more
NCT07471490 · IBD (Inflammatory Bowel Disease), IBS (Irritable Bowel Syndrome), and more
NCT07539077 · IBD (Inflammatory Bowel Disease), IBS (Irritable Bowel Syndrome)
Linköping University Hospital
Linköping, Linköping
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions